Timing of P2Y12 Inhibitor Administration in Patients With STEMI Undergoing Primary PCI,Journal of the American College of Cardiology

当前位置： X-MOL 学术 › J. Am. Coll. Cardiol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Timing of P2Y12 Inhibitor Administration in Patients With STEMI Undergoing Primary PCI
Journal of the American College of Cardiology ( IF 21.7 ) Pub Date : 2024-06-17 , DOI: 10.1016/j.jacc.2024.04.036
Manuel Almendro-Delia ₁ , Begoña Hernández-Meneses ₁ , Gloria Padilla-Rodríguez ₁ , Emilia Blanco-Ponce ₂ , Jose Andres Arboleda-Sánchez ₃ , Juan Carlos Rodríguez-Yáñez ₄ , José Manuel Soto-Blanco ₅ , Isabel Fernández-García ₆ , José M Castillo-Caballero ₇ , Juan C García-Rubira ₁ , Rafael Hidalgo-Urbano ₁

Affiliation

The optimal timing of P2Y12 inhibitor administration in patients with ST-segment elevation myocardial infarction (STEMI) has not been completely elucidating.

中文翻译：